TMC649128
Sponsors
Tibotec Pharmaceuticals, Ireland, Tibotec BVBA
Conditions
Healthy VolunteerHepatitis C Virus
Phase 1
TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers
CompletedNCT01288677
Start: 2011-01-31End: 2011-06-30Updated: 2013-03-20
TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin
TerminatedNCT01391117
Start: 2011-06-30End: 2011-11-30Updated: 2012-10-26